'Pivotal' trial results display favorable outcomes for use of TPV device

A percutaneous transcatheter therapy for congenital heart disease (CHD) patients with severe pulmonary regurgitation (PR) has been slow to materialize, in comparison ... Read more

Bron:

EurekAlert! - Breaking News